![Russia Registers First Coronavirus Vaccine](https://tsarizm.com/wp-content/uploads/2020/08/p-2.jpg)
Today Russian President Vladimir Putin announced the Russian Federation had registered the first vaccine for the Chinese coronavirus, saying it was safe and effective. Some analysts questioned the safety of the vaccine as Russia essentially skipped phase III trials before registering the medication.
The Russian leader noted that the first Russian COVID-19 vaccine forms stable cell and antibody immunity, reported Russian state news agency TASS.
“As far as I know, this morning for the first time in the world a vaccine against the novel coronavirus infection was registered,” the president said.
“I know this very well, because one of my daughters got vaccinated, so in this sense, she took part in testing,” Putin said. He noted that after the first vaccine shot, his daughter had a 38°C fever, and on the next day, a fever slightly higher than 37°C. “And then, after the second shot, she had a slight fever again, and then everything was fine, she is feeling well and has a high [antibody] count,” the president informed.
The Russian leader pointed out that “some people do not have any symptoms at all” after getting a vaccine shot.
The state-run Gamaleya research institute last week launched Phase III trials of the Covid-19 vaccine involving thousands of volunteers. The Health Ministry has said it plans to begin mass production of the vaccine as soon as next month and launch a mass vaccination drive in October, reported The Moscow Times.
Its registration certificate on the Health Ministry website notes that the vaccine, an injection solution called “Sputnik-V,” will enter civilian circulation on Jan. 1, 2021.
- One Protester Killed In Minsk During Demonstrations As Violence Erupts
- Yes, Russia Could Work With US Against China
2 comments
They already had it before they release the Bio-Weapon.
Gates and Fauchi ar not going to allow this. Everyone knows if anyone is going to profit from this faux pandemic, it’s going to be them.